Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss doesn't affect COVID-19 severity.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Finasteride 1mg helps reverse hair miniaturization in men and postmenopausal women.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

The dietary supplement helped increase hair growth in women with hair loss.

A systematic approach is crucial for managing hair loss in women.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Women with irregular periods have a higher risk of heart disease.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.